Gregory Steinberg
Gregory Steinberg
Verified email at
Cited by
Cited by
Adipose tissue as an endocrine organ
S Galic, JS Oakhill, GR Steinberg
Molecular and cellular endocrinology 316 (2), 129-139, 2010
AMPK in health and disease
GR Steinberg, BE Kemp
Physiological reviews 89 (3), 1025-1078, 2009
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
AL Carey, GR Steinberg, SL Macaulay, WG Thomas, AG Holmes, ...
Diabetes 55 (10), 2688-2697, 2006
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
MD Fullerton, S Galic, K Marcinko, S Sikkema, T Pulinilkunnil, ZP Chen, ...
Nature medicine 19 (12), 1649-1654, 2013
The ancient drug salicylate directly activates AMP-activated protein kinase
SA Hawley, MD Fullerton, FA Ross, JD Schertzer, C Chevtzoff, KJ Walker, ...
Science 336 (6083), 918-922, 2012
Energy-stress-mediated AMPK activation inhibits ferroptosis
H Lee, F Zandkarimi, Y Zhang, JK Meena, J Kim, L Zhuang, S Tyagi, L Ma, ...
Nature cell biology 22 (2), 225-234, 2020
Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling
GR Steinberg, BJ Michell, BJW van Denderen, MJ Watt, AL Carey, ...
Cell metabolism 4 (6), 465-474, 2006
AMPK as a therapeutic target for treating metabolic diseases
EA Day, RJ Ford, GR Steinberg
Trends in Endocrinology & Metabolism 28 (8), 545-560, 2017
Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36
A Bonen, ML Parolin, GR Steinberg, J Calles‐Escandon, NN Tandon, ...
The FASEB Journal 18 (10), 1144-1146, 2004
AMP-activated protein kinase: the current landscape for drug development
GR Steinberg, D Carling
Nature reviews Drug discovery 18 (7), 527-551, 2019
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis
JD Crane, R Palanivel, EP Mottillo, AL Bujak, H Wang, RJ Ford, A Collins, ...
Nature medicine 21 (2), 166-172, 2015
AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity
HM O’Neill, GP Holloway, GR Steinberg
Molecular and cellular endocrinology 366 (2), 135-151, 2013
AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise
HM O'Neill, SJ Maarbjerg, JD Crane, J Jeppesen, SB Jørgensen, ...
Proceedings of the National Academy of Sciences 108 (38), 16092-16097, 2011
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus
BG Drew, SJ Duffy, MF Formosa, AK Natoli, DC Henstridge, SA Penfold, ...
Circulation 119 (15), 2103-2111, 2009
Treatment of nonalcoholic fatty liver disease: role of AMPK
BK Smith, K Marcinko, EM Desjardins, JS Lally, RJ Ford, GR Steinberg
American Journal of Physiology-Endocrinology and Metabolism 311 (4), E730-E740, 2016
Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro
EW Petersen, AL Carey, M Sacchetti, GR Steinberg, SL Macaulay, ...
American Journal of Physiology-Endocrinology and Metabolism 288 (1), E155-E162, 2005
Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis
SL Pinkosky, RS Newton, EA Day, RJ Ford, S Lhotak, RC Austin, ...
Nature Communications 7 (1), 13457, 2016
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
S Galic, MD Fullerton, JD Schertzer, S Sikkema, K Marcinko, CR Walkley, ...
The Journal of clinical investigation 121 (12), 4903-4915, 2011
MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis
M Ouimet, HN Ediriweera, UM Gundra, FJ Sheedy, B Ramkhelawon, ...
The Journal of clinical investigation 125 (12), 4334-4348, 2015
The Na+/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels
SA Hawley, RJ Ford, BK Smith, GJ Gowans, SJ Mancini, RD Pitt, EA Day, ...
Diabetes 65 (9), 2784-2794, 2016
The system can't perform the operation now. Try again later.
Articles 1–20